Dr. Pawan Kumar Singh
Director
Centre For Bone Marrow Transplant
- Dr Singh has the experience of performing more than 500 bone marrow transplants (including Autologous/Allogenic/Haplo/MUD) for both malignant and non-malignant disorders.
- Dr Singh is successfully running the HSCT (Autologous) programme for Auto-immune diseases at Sanar International Hospitall especially Multiple Sclerosis and Systemic Sclerosis.
Area Of Interest And Expertise
- Experience in performing complicated BMTs like BMT in HIV and Hepatitis virus infected patients, Bloodless BMT in Jehovah witness cases, BMT in patients on dialysis and many more.
- BMT in Thalassemia and Sickle Cell Disease.
Qualification
- MBBS
- MD (Internal Medicine)
- DM (Haematology)
Membership
- Indian Society of Haematology & Blood Transfusion.
- European Haematology Association.
Experience
Previous Experience:
- Senior Consultant and Head of Department - Hemato-oncology and BMT at Artemis Hospital, Gurgaon
- Associate Consultant - Department of Haemato-oncology and BMT at Jaypee Hospital, Noida
- Senior Resident - Department of Haematology at All India Institute of Medical Sciences, New Delhi
- Senior Registrar - Department of Haematology at Christian Medical College, Vellore
Frequently Asked Questions
A marrow transplant, also known as a stem cell transplant, involves the infusion of healthy blood-forming stem cells to replace damaged or diseased bone marrow. This procedure is often used to treat conditions such as leukemia, lymphoma, and certain genetic disorders.
Marrow transplants are considered the best option when other treatments have failed or when a patient’s condition requires the replacement of damaged or non-functioning bone marrow. It offers the possibility of long-term remission or cure for certain blood disorders.
There are two main types of marrow transplants: autologous, where a patient’s own stem cells are used, and allogeneic, where stem cells from a donor (usually a family member or unrelated donor) are used. The choice of transplant type depends on the patient’s diagnosis and other factors.
Finding a suitable donor involves matching human leukocyte antigens (HLA), which are proteins on the surface of cells. Family members are often the first choice, but unrelated donors can be found through national and international registries. The best match increases the chances of transplant success.
Success rates vary depending on factors such as the type of transplant, the underlying condition, the patient’s age, and overall health. Allogeneic transplants may have a higher risk of complications but offer the potential for a cure. Autologous transplants may have a lower risk of complications but may not provide a cure in certain cases.
Recovery varies, but patients typically spend several weeks to months in the hospital for close monitoring. It may take several months to a year or more to fully recover and return to normal activities. Follow-up care is crucial for monitoring long-term effects and preventing complications.
Best Doctor for BMT
Get Opinion from the expert for most effective treatment approach